American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options
2015 · Journal of Clinical Oncology · 897 citations
https://doi.org/10.1200/jco.2015.61.6706
R
Richard L. Schilsky
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
559
Papers
39.6K
Citations
92
h-index
318
i10-index
Richard L. Schilsky is an academic researcher from American Society of Clinical Oncology. The author has contributed to research in topics: Colorectal Cancer Treatments and Studies & Cancer Genomics and Diagnostics & Lung Cancer Treatments and Mutations. The author has an h-index of 92, co-authored 476 publications.
ORCID: 0000-0003-4474-4303Papers by this author
worksOral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trials
2004 · British Journal of Cancer · 396 citations
https://doi.org/10.1038/sj.bjc.6601676
The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs
2019 · Nature · 252 citations
https://doi.org/10.1038/s41586-019-1600-x
Clinical Cancer Advances 2021: ASCO's Report on Progress Against Cancer
2021 · Journal of Clinical Oncology · 89 citations
https://doi.org/10.1200/jco.20.03420
Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ
2024 · JAMA · 58 citations
https://doi.org/10.1001/jama.2024.26698
Pertuzumab Plus Trastuzumab in Patients With Colorectal Cancer With<i>ERBB2</i>Amplification or<i>ERBB2/3</i>Mutations: Results From the TAPUR Study
2022 · JCO Precision Oncology · 57 citations
https://doi.org/10.1200/po.22.00306
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat